- AU$47.94m
- AU$56.50m
- AU$60.25m
Annual income statement for Compumedics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 37.8 | 42.4 | 49.7 | 50.8 | 60.3 |
| Cost of Revenue | |||||
| Gross Profit | 19.3 | 21.6 | 26.1 | 27.9 | 31 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 35.8 | 48.5 | 48.3 | 49.9 | 56.8 |
| Operating Profit | 1.93 | -6.11 | 1.4 | 0.896 | 3.44 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 1.7 | -6.72 | 0.48 | -0.411 | 1.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.36 | -6.12 | -0.338 | -1.27 | 0.253 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1.36 | -6.12 | -0.338 | -1.27 | 0.253 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.36 | -6.12 | -0.338 | -1.27 | 0.253 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.003 | -0.023 | -0.008 | -0.007 | 0.001 |